Fangfang Lü

Statistics

Publications

Citations

539

H-Index

Active since

2011

Affiliations

Shanghai Children's Medical Center(Current)

Fangfang Lü is an author at Shanghai Children's Medical Center specializing in medicine, perioperative outcomes research, and c-reactive protein testing.

Publications per year

2011–2016

Publications

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>

Shu Tian, Haitian Quan, Chengying Xie et al. · Cancer Science · 2011 · 521 citations · Full text

Medicine, Oncology, Pharmacology +17

Circulating histones for predicting prognosis after cardiac surgery: a prospective study

Hongxiang Gao, Naipu Zhang, Fangfang Lü et al. · Interactive Cardiovascular and Thoracic Surgery · 2016 · 18 citations · Full text

Medicine, Cardiology, Surgery +12

1–2 of 2